BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 38497886)

  • 21. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
    Zhu K; Ma J; Tian Y; Liu Q; Zhang J
    BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
    Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer.
    Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J
    J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
    Xiang SY; Li QK; Yang Z; Yi Q
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.